期刊文献+

Prognostic value of neutrophil distribution in cholangiocarcinoma 被引量:4

Prognostic value of neutrophil distribution in cholangiocarcinoma
下载PDF
导出
摘要 AIM:To explore the relationship of clinicopathological features and the distribution of neutrophils in the t umor mic roenvironment wi t h t he prognosis of cholangiocarcinoma.METHODS:Two hundred and fifty-four formalin-fixed and paraffin embedded tissue blocks were analyzed, including tissues from cholangiocarcinoma(n = 254), and tumor adjacent tissues(n = 238).Tissue sections were stained for CD15 using immunohistochemical staining.CD15 expression was detected to identify the distribution of neutrophils in the local tumor microenvironment.The neutrophil density of the tumor tissues and the adjacent tumor tissues was detected to reflect their inflammatory status.Clinical data and follow-up information of cholangiocarcinoma patients who underwent surgery from January 2004 to December 2010 were analyzed retrospectively.The relationship between clinicopathological features and the distribution of neutrophils with prognosis of the patients were analyzed.RESULTS:The positive expression level of CD15 was only significantly related to the TNM stage.CD15 expression was higher in tumor tissues than in adjacent tissues(73.6% vs 54.6%), with significant differences.Patients with high expression of CD15 had significantly shorter overall survival(OS) than those with low expression of CD15(median overall survival time 39.77 mo vs 16.87 mo, P = 0.008).Patients with high CD15 expression had significantly shorter disease free survival time(DFS) than those with low expression of CD15(median DFS 38.27 mo vs 16.83 mo, P = 0.029).COX multivariate analysis indicated that high CD15 expression in tumor tissues was an independent risk factor for predicting OS for patients with cholangiocarcinoma [P = 0.012, relative risk(RR) = 1.601], but it was not an independent risk factor for predicting DFS(P = 0.073, RR = 1.462).CONCLUSION:Patients with high CD15 expression in cancer tissues had shorter DFS and OS.High expression of CD15 is an independent risk factor for OS. AIM:To explore the relationship of clinicopathological features and the distribution of neutrophils in the t umor mic roenvironment wi t h t he prognosis of cholangiocarcinoma.METHODS:Two hundred and fifty-four formalin-fixed and paraffin embedded tissue blocks were analyzed, including tissues from cholangiocarcinoma(n = 254), and tumor adjacent tissues(n = 238).Tissue sections were stained for CD15 using immunohistochemical staining.CD15 expression was detected to identify the distribution of neutrophils in the local tumor microenvironment.The neutrophil density of the tumor tissues and the adjacent tumor tissues was detected to reflect their inflammatory status.Clinical data and follow-up information of cholangiocarcinoma patients who underwent surgery from January 2004 to December 2010 were analyzed retrospectively.The relationship between clinicopathological features and the distribution of neutrophils with prognosis of the patients were analyzed.RESULTS:The positive expression level of CD15 was only significantly related to the TNM stage.CD15 expression was higher in tumor tissues than in adjacent tissues(73.6% vs 54.6%), with significant differences.Patients with high expression of CD15 had significantly shorter overall survival(OS) than those with low expression of CD15(median overall survival time 39.77 mo vs 16.87 mo, P = 0.008).Patients with high CD15 expression had significantly shorter disease free survival time(DFS) than those with low expression of CD15(median DFS 38.27 mo vs 16.83 mo, P = 0.029).COX multivariate analysis indicated that high CD15 expression in tumor tissues was an independent risk factor for predicting OS for patients with cholangiocarcinoma [P = 0.012, relative risk(RR) = 1.601], but it was not an independent risk factor for predicting DFS(P = 0.073, RR = 1.462).CONCLUSION:Patients with high CD15 expression in cancer tissues had shorter DFS and OS.High expression of CD15 is an independent risk factor for OS.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第16期4961-4968,共8页 世界胃肠病学杂志(英文版)
关键词 CHOLANGIOCARCINOMA Surgery NEUTROPHILS CD15 PROGNOSIS Tumor MICROENVIRONMENT Cholangiocarcinoma Surgery Neutrophils CD15 Prognosis Tumor microenvironment
  • 相关文献

参考文献50

  • 1Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, ElGhormli L, Olsen JH, McGlynn KA. Risk factors for intrahepaticcholangiocarcinoma in a low-risk population: a nationwide casecontrolstudy. Int J Cancer 2007; 120: 638-641 [PMID: 17109384DOI: 10.1002/ijc.22283].
  • 2Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F,Martelli C, Savio A, Trevisi P, Nardi G. Intrahepatic cholangiocarcinomaand hepatitis C and B virus infection, alcohol intake,and hepatolithiasis: a case-control study in Italy. Cancer CausesControl 2001; 12: 959-964 [PMID: 11808716 DOI: 10.1023/A:1013747228572].
  • 3El-Serag HB, Engels EA, Landgren O, Chiao E, HendersonL, Amaratunge HC, Giordano TP. Risk of hepatobiliary andpancreatic cancers after hepatitis C virus infection: A populationbasedstudy of U.S. veterans. Hepatology 2009; 49: 116-123 [PMID:19085911 DOI: 10.1002/hep.22606].
  • 4Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA.Risk factors of intrahepatic cholangiocarcinoma in the UnitedStates: a case-control study. Gastroenterology 2005; 128: 620-626[PMID: 15765398].
  • 5Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, LeeSK, Seo DW, Kim MH, Suh DJ. Hepatitis B virus infection andintrahepatic cholangiocarcinoma in Korea: a case-control study.Am J Gastroenterol 2008; 103: 1716-1720 [PMID: 18557716 DOI:10.1111/j.1572-0241.2008.01796.x].
  • 6Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, Wang YL,Li DQ. Risk factors for intrahepatic cholangiocarcinoma: a casecontrolstudy in China. World J Gastroenterol 2008; 14: 632-635[PMID: 18203300 DOI: 10.3748/wjg.14.632].
  • 7Sekiya S, Suzuki A. Intrahepatic cholangiocarcinoma can arisefrom Notch-mediated conversion of hepatocytes. J Clin Invest2012; 122: 3914-3918 [PMID: 23023701 DOI: 10.1172/JCI63065].
  • 8Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, ShutoT, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T.Hepatitis C virus infection as a likely etiology of intrahepaticcholangiocarcinoma. Cancer Sci 2004; 95: 592-595 [PMID:15245596 DOI: 10.1111/j.1349-7006.2004.tb02492.x].
  • 9Chapman MH, Webster GJ, Bannoo S, Johnson GJ, Wittmann J,Pereira SP. Cholangiocarcinoma and dominant strictures in patientswith primary sclerosing cholangitis: a 25-year single-centreexperience. Eur J Gastroenterol Hepatol 2012; 24: 1051-1058[PMID: 22653260 DOI: 10.1097/MEG.0b013e3283554bbf].
  • 10Bergquist A, Ekbom A, Olsson R, Kornfeldt D, L--f L, DanielssonA, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzén H, AlmerS, Granath F, Broomé U. Hepatic and extrahepatic malignanciesin primary sclerosing cholangitis. J Hepatol 2002; 36: 321-327[PMID: 11867174 DOI: 10.1016/S0168-8278(01)00288-4].

同被引文献9

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部